{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/1408928442",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1830681485"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#1408928442",
  "code": "BC43.10",
  "source": "http://id.who.int/icd/entity/1408928442",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Familial-genetic hypertrophic cardiomyopathy"
  },
  "definition": {
    "@language": "en",
    "@value": "Familial isolated hypertrophic cardiomyopathy is the presence of non-syndromic hypertrophic cardiomyopathy in multiple members of a pedigree, or in the presence of a genetic mutation known to be significantly associated with hypertrophic cardiomyopathy."
  },
  "relatedEntitiesInMaternalChapter": [
    "http://id.who.int/icd/entity/1218807936"
  ],
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Familial-genetic hypertrophic cardiomyopathy"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Familial hypertrophic cardiomyopathy"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hereditary ventricular hypertrophy"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to disorder of fatty acid metabolism"
      },
      "foundationReference": "http://id.who.int/icd/entity/1868316982"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Fatty acid oxidation or ketogenesis disorder with hypertrophic cardiomyopathy"
      },
      "foundationReference": "http://id.who.int/icd/entity/1868316982"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to carnitine palmitoyl transferase II deficiency"
      },
      "foundationReference": "http://id.who.int/icd/entity/1206761127"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to Carnitine-acylcarnitine translocase deficiency"
      },
      "foundationReference": "http://id.who.int/icd/entity/1678387326"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to carnitine deficiency"
      },
      "foundationReference": "http://id.who.int/icd/entity/977387677"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to glycogen storage disease"
      },
      "foundationReference": "http://id.who.int/icd/entity/1082975408"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Glycogen storage disease with hypertrophic cardiomyopathy"
      },
      "foundationReference": "http://id.who.int/icd/entity/1082975408"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to AMP-activated protein kinase deficiency"
      },
      "foundationReference": "http://id.who.int/icd/entity/117446132"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to PRKAG2 syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/56130396"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to Pompe disease"
      },
      "foundationReference": "http://id.who.int/icd/entity/2976375"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to glycogen debranching enzyme deficiency"
      },
      "foundationReference": "http://id.who.int/icd/entity/663475280"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to LAMP2 deficiency disease"
      },
      "foundationReference": "http://id.who.int/icd/entity/1558747617"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to lysosomal storage disease"
      },
      "foundationReference": "http://id.who.int/icd/entity/1286416076"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Lysosomal disease with hypertrophic cardiomyopathy"
      },
      "foundationReference": "http://id.who.int/icd/entity/1286416076"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to Anderson–Fabry disease"
      },
      "foundationReference": "http://id.who.int/icd/entity/1355924020"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to Hurler disease"
      },
      "foundationReference": "http://id.who.int/icd/entity/1322160706"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to Hurler disease (MPS I)"
      },
      "foundationReference": "http://id.who.int/icd/entity/1322160706"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to mitochondrial disorder"
      },
      "foundationReference": "http://id.who.int/icd/entity/1669169994"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Mitochondrial disease with hypertrophic cardiomyopathy"
      },
      "foundationReference": "http://id.who.int/icd/entity/1669169994"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to MELAS"
      },
      "foundationReference": "http://id.who.int/icd/entity/1093002892"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to MELAS - [Mitochondrial Encephalopathy, Lactic acidosis, and Stroke-like episodes]"
      },
      "foundationReference": "http://id.who.int/icd/entity/1093002892"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to Friedreich's ataxia"
      },
      "foundationReference": "http://id.who.int/icd/entity/1103109660"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Other specified familial diseases associated with hypertrophic cardiomyopathy"
      },
      "foundationReference": "http://id.who.int/icd/entity/1717581988"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to primary amyloidosis"
      },
      "foundationReference": "http://id.who.int/icd/entity/740055297"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Sarcomeric hypertrophic cardiomyopathy"
      },
      "foundationReference": "http://id.who.int/icd/entity/1391917183"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Syndromic hypertrophic cardiomyopathy"
      },
      "foundationReference": "http://id.who.int/icd/entity/1540317046"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to craniofacialcutaneous syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/346856943"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to Noonan syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/142365620"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to Noonan syndrome with multiple lentigines"
      },
      "foundationReference": "http://id.who.int/icd/entity/1674938293"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to LEOPARD syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/1674938293"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to Costello syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/1660653061"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to Beckwith–Wiedemann syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/1562044179"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to Swyer's syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/675912688"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to Leprechaunism"
      },
      "foundationReference": "http://id.who.int/icd/entity/933051046"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hypertrophic cardiomyopathy due to Donohue syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/933051046"
    }
  ]
}